Skydance Corporation (SKYD) reported third-quarter earnings of $0.45 per share, beating the $0.18 consensus by 150.0%. Revenue of $7.025 billion slightly missed the $7.07 billion consensus, by 0.6%. The quarter reflects Paramount Skydance alone, before the October 6 close of the Warner Bros. Discovery acquisition. That timing is the central tension. The reported numbers describe a standalone business that is clearly executing better, while the investment case now rests on a much larger, more leveraged combined company whose first disclosed problem, the Warner Bros. film slate, arrived alongside the beat.

The quality of the standalone quarter is better than the slight revenue miss suggests. Management said revenue rose 5% year over year and adjusted EBITDA came in around $1 billion, above the top of the $875-975 million range it set on the second-quarter call. The earnings beat looks driven by operating leverage and cost discipline rather than top-line upside. The Paramount efficiency program is on track for a $2.7 billion run rate by year-end, against a target already raised to $3 billion-plus. Cash generation improved sharply. Free-cash-flow conversion excluding transformation costs is now about 30%, compared with guidance of at least 10% on the Q2 call and just 5% in the fourth quarter of 2025. Standalone 2026 adjusted EBITDA guidance of $3.9 billion, the high end of the previously raised range, was reaffirmed. The press release itself offered little detail, deferring to a shareholder letter, so the call carried most of the substance.

The strongest operating signal was streaming. Paramount+ revenue growth accelerated to 21% from 16% in the second quarter and 17% in the first. Engagement rose more than 20%, and pro forma combined direct-to-consumer revenue grew 15%. That gives the planned Paramount+/HBO Max bundle, launching in early 2027, a firmer foundation than a purely defensive consolidation story would have. Management also outlined a converged technology stack within roughly a year. Its tone was noticeably more expansive, and it framed revenue synergies as upside not included in its plan.

The forward framework is ambitious:

• A $6 billion-plus run-rate synergy program over three years, with 30% targeted by end-2027 and 70% by end-2028, at a $4 billion cash cost.
• Medium-term targets of mid-single-digit revenue growth and mid-20s adjusted EBITDA margins.
• More than $10 billion of free cash flow in 2030.
• Net leverage below 3x by end-2029 without asset sales.

Near-term catalysts include the Harry Potter series premiering Christmas Day, a 30-plus film slate in 2027, Jeremy Latcham's hiring to lead DC Studios and an Investor Day in the first half of 2027.

Bears have legitimate ammunition, however. The Warner Bros. film slate is underperforming and will cost roughly $200 million of fourth-quarter adjusted EBITDA. Management now expects slower studio revenue and EBITDA growth than previously anticipated, a notable retreat from the second-quarter framing of the studio as a durable growth engine. The combination also carries significantly higher leverage. Free cash flow for 2027 is guided only to breakeven or better, including $1.5-2 billion of synergy costs. Consent-decree commitments add structural obligations, which management says were already planned:

• 30 theatrical releases a year in years one and two, rising to 32 in years three through five.
• An additional $300 million of annual U.S. production.
• Five-year ownership of both studio lots.

The shift from quarterly to annual guidance reduces near-term visibility just as integration risk peaks, and linear TV decline remains structural.

Investor sentiment entered the report firmly positive at 0.65, suggesting the beat landed with a receptive audience. No prior reading is available to show whether expectations were building or fading. The stock tells a more cautious story. At $8.01 before the report, shares sat essentially at their 200-day moving average of $8.06, about 0.6% below it. That is the posture of a market waiting for evidence that the combined company can deliver, not one pricing in the synergy math. Supplementary trend readings lean modestly positive on balance, but the price action itself shows little conviction either way.

The bottom line is that Skydance delivered a high-quality standalone beat, with accelerating Paramount+ growth, EBITDA above guidance and a striking improvement in cash conversion. The quarter, however, is now a rear-view mirror. The investment case has shifted to a leveraged, multi-year integration with an early studio setback, breakeven 2027 free cash flow and less frequent guidance. Execution on the $6 billion synergy plan and the 2027 bundle launch, not the size of this EPS surprise, will determine whether shares can move decisively off their 200-day average.